Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Frank, Grieger"'
Autor:
Thomas M Schindler, Frank Grieger, Anna Zak, Ramona Rorig, Kavya Chowdary Konka, Anna Ellsworth, Christopher Pfitzer, Keir Hodge, Christine Crandall, TransCelerate Clinical Research Access & Information Exchange Initiative
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0233294 (2020)
ClinicalTrials.gov was started with the intention to create a consumer-friendly database for patients and others in search of information on clinical trials. However, there is no research on whether the content of ClinicalTrials.gov aligns with patie
Externí odkaz:
https://doaj.org/article/dcd4cb3c65294a0188d39274f149fb15
Autor:
A. Pokrovsky, A. Ratushnyuk, G. Hamm, J. W. G. Bentz, O. Randerath, H. Lawall, Frank Grieger, P. Checinski
Publikováno v:
European Journal of Vascular and Endovascular Surgery. 53:559-566
Objectives The aim was to assess the efficacy and safety of alprostadil in patients with peripheral arterial occlusive disease (PAOD) Fontaine Stage IV. Methods This was a multinational, prospective, randomised, double blind, placebo controlled, para
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a5a5771c481d4284e5cc9ab313e0741
https://doi.org/10.1016/j.ejvs.2016.12.035
https://doi.org/10.1016/j.ejvs.2016.12.035
Autor:
Kallol Ray Chaudhuri, Lars Bauer, Angelo Antonini, Mahnaz Asgharnejad, Babak Boroojerdi, Frank Grieger, Daniel Weintraub
Publikováno v:
European Journal of Neurology
Background and purpose Dopamine agonists in Parkinson's disease (PD) are associated with impulse control disorders (ICDs) and other compulsive behaviours (together called ICD behaviours). The frequency of ICD behaviours reported as adverse events (AE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93ecfd4176df9e353a19677f174e50e2
http://europepmc.org/articles/PMC5096013
http://europepmc.org/articles/PMC5096013
Publikováno v:
Journal of Parkinson's Disease
Background: Monoamine oxidase B (MAO-B) inhibitors and dopamine receptor agonists are common first-line treatment options in early Parkinson’s disease (PD). Objective: To evaluate the efficacy and safety of rotigotine transdermal patch as an add-on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::838b1e8bac7228f1952a90351d60d410
https://doi.org/10.3233/jpd-150758
https://doi.org/10.3233/jpd-150758
Autor:
Frank Grieger, Karl Kesper, Axel Bauer, Claudia Trenkwalder, Lars Joeres, Werner Cassel, Erwin Schollmayer
Publikováno v:
Sleep Medicine. 17:109-120
Objective A new and unique methodology was developed to evaluate the association between periodic limb movements (PLMs) and nocturnal blood pressure (BP) excursions in patients with restless legs syndrome (RLS). Methods All data were collected at bas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::489a74eeb2487e00e93b97eae1e950e4
https://doi.org/10.1016/j.sleep.2014.12.019
https://doi.org/10.1016/j.sleep.2014.12.019
Autor:
Reinhard Berkels, Frank Grieger, Jan Kassubek, Thomas Müller, Thomas Lauterbach, Lars Timmermann, Dirk Woitalla
Publikováno v:
Parkinsonism & Related Disorders. 21:199-204
Introduction Gastrointestinal (GI) symptoms are common among patients with Parkinson's disease (PD), due to both the disease itself and anti-PD drugs. We hypothesized that transdermal drug administration may result in fewer GI problems. This prospect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28e3a0b0ecb2c6a6e8df3519aa44eac1
https://doi.org/10.1016/j.parkreldis.2014.11.024
https://doi.org/10.1016/j.parkreldis.2014.11.024
Autor:
Frank Grieger, Kimberly Moran, Arthur S. Walters, Heike Benes, Wolfgang H. Oertel, Ralf Kohnen, Richard P. Allen, Erwin Schollmayer
Publikováno v:
Sleep Medicine. 14:1375-1380
Background The SP790 study (ClinicalTrials.gov, NCT00136045 ) showed benefits of rotigotine over placebo in improving symptom severity of restless legs syndrome (RLS), also known as Willis-Ekbom disease, on the International Restless Legs Syndrome St
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fd4cea2b5f26f2bc01a9718fe714938
https://doi.org/10.1016/j.sleep.2013.09.008
https://doi.org/10.1016/j.sleep.2013.09.008
Autor:
Cornelius G. Bachmann, Reinhard Berkels, Daniela Berg, Thomas Lauterbach, Karin Stiasny-Kolster, Frank Grieger, Werner Hofmann, Erwin Schollmayer
Publikováno v:
Sleep Medicine. 14:475-481
Objective We aimed to assess effectiveness and tolerability of rotigotine in patients with moderate to severe idiopathic restless legs syndrome (RLS) under daily practice conditions in Germany. Methods In this 3-month noninterventional study, effecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7f04c8afa474a378a6b9014a838c9aa
https://doi.org/10.1016/j.sleep.2013.02.013
https://doi.org/10.1016/j.sleep.2013.02.013
Autor:
Lars Bauer, Babak Boroojerdi, Peter A LeWitt, Mahnaz Asgharnejad, Werner Poewe, Lawrence Elmer, Frank Grieger
Publikováno v:
Clinical Neuropharmacology
In many patients with Parkinson's disease (PD), the long-term use of levodopa becomes complicated by the development of motor complications including “wearing-off” fluctuations and drug-induced dyskinesias.1–4 Fluctuations in medication respons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ddd18d25db5aff752341106ff3059f7
https://pubmed.ncbi.nlm.nih.gov/26882318
https://pubmed.ncbi.nlm.nih.gov/26882318
Autor:
Frank Grieger, Kimberly Moran, René Smit, John D. Hudson, John W. Winkelman, Erwin Schollmayer, Elisabeth Dohin, Richard P. Allen, Diego Garcia-Borreguero
Publikováno v:
Current medical research and opinion. 32(1)
This 12 week double-blind, placebo-controlled study (ClinicalTrials.gov: NCT01569464) was conducted to evaluate the effects of rotigotine transdermal patch on daytime symptoms in patients with idiopathic restless legs syndrome (RLS).Adult patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50ecd291c7ff4fbf79b96701cbbdf62f
https://pubmed.ncbi.nlm.nih.gov/26569149
https://pubmed.ncbi.nlm.nih.gov/26569149